资源类型:
期刊
文章类型:
论著
机构:
[a]Department of Neurosurgery, Yuhuangding Hospital of Yantai, 20 Yuhuangding East Road, Yantai, Shandong, 264000, China
[b]Department of Cadre Health Care, Fuxing Hospital, Capital Medical University, Beijing, 100038, China
[c]Department of Endocrinology, Tiantan Hospital, Capital Medical University, Beijing, 100050, China
首都医科大学附属天坛医院
ISSN:
1574-3624
关键词:
Glioblastoma multiforme
microRNAs
Therapeutic targets
摘要:
Pioneer works have identified some microRNAs (miRNAs) with oncogenic or tumor-suppressive properties in glioblastoma multiforme (GBM), an aggressive brain tumor with dismal prognosis. Differential expression of these noncoding small RNA in cancers positions them as attractive biomarkers for diagnosis, prognosis and therapeutic decision in GBMs. In addition, abnormal miRNAs provide new interesting therapeutic targets for clinical GBM treatments despite the hurdles associated with such an approach. This review firstly summarizes abnormal expressed genes and upstream miRNAs in GBMs. Next, our focus will be towards the signature of miRNAs in GBM, and discuss the importance of circulating miRNAs for cancer diagnosis. Finally, we summarize present miRNA target therapeutic strategies, and discuss the deficiencies and challenges. © 2014 Bentham Science Publishers.
中科院(CAS)分区:
出版当年[2013]版:
大类
|
4 区
医学
小类
|
4 区
药学
第一作者:
Xiu, C
推荐引用方式(GB/T 7714):
Xiu C,Qi W,Wang Y,et al.Perspective of MiRNAs in clinical glioblastoma research[J].2014,9(1):doi:10.2174/1574362409666140724183754.
APA:
Xiu, C,Qi, W,Wang, Y,Zhang, H&Chi, N.(2014).Perspective of MiRNAs in clinical glioblastoma research.,9,(1)
MLA:
Xiu, C,et al."Perspective of MiRNAs in clinical glioblastoma research". 9..1(2014)